AKAP12 positive fibroblast determines immunosuppressive contexture and immunotherapy response in patients with TNBC by promoting macrophage M2 polarization
View abstract on PubMed
Summary
This summary is machine-generated.Cancer-associated fibroblasts expressing AKAP12 promote triple-negative breast cancer (TNBC) immune suppression and poor prognosis. Targeting IL-34 may improve immunotherapy for TNBC patients.
Area Of Science
- Oncology
- Immunology
- Cancer Biology
Background
- Triple-negative breast cancer (TNBC) is aggressive with poor prognosis.
- Cancer-associated fibroblasts (CAFs) significantly influence TNBC progression and treatment.
- Identifying specific CAFs subpopulations is crucial for understanding TNBC development.
Purpose Of The Study
- To identify CAFs subpopulations contributing to TNBC development.
- To investigate the role of AKAP12+ CAFs in the TNBC microenvironment.
- To explore AKAP12+ CAFs' association with immunotherapy response and prognosis.
Main Methods
- Multiomics analyses (cytometry by time-of-flight, RNA sequencing) were used.
- AKAP12+ CAFs and their clinical significance in 80 TNBC patients were assessed.
- Immunofluorescence assays elucidated the immune landscape and functional mechanisms.
Main Results
- An AKAP12+ CAFs subset associated with immunotherapy response was identified.
- High AKAP12+ CAFs population correlated with poor TNBC prognosis.
- AKAP12+ CAFs promote an immunosuppressive microenvironment via IL-34/CSF1R signaling, mediating macrophage M2 polarization.
Conclusions
- AKAP12+ CAFs are negatively associated with TNBC patient prognosis.
- AKAP12+ CAFs contribute to an immunosuppressive TNBC microenvironment by promoting M2 macrophage polarization.
- Targeting IL-34 shows potential to enhance TNBC immunotherapy efficacy.
Related Concept Videos
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...

